Both the stimulus bill (i.e., The American Recovery and Reinvestment Act of 2009 [ARRA]) and Obamacare (the Affordable Care Act [ACA]) contain provisions to increase funding for compariative effectiveness research (CER). According to a Deloitte Issue Brief,
ARRA provided the foundation for the ACA’s newly mandated and immediately effective CER entity, the Patient-Centered Outcomes Research Institute (PCORI). Bysponsoring scientifically rigorous CER studies, PCORI will be responsible for assisting patients, clinicians, payers, and policy makers in making informed health care decisions by advancing the quality and relevance of evidence.
How do different countries use comparative effectiveness research? This chart provides a nice summary.
- Comparative Effectiveness Research in the United States: Update and implications. Deloitte Issue Brief.